ES8504796A1 - Un procedimiento para preparar 5,14-dihidrobenz(5,6)isoindolo(2,1-b)isoquinolein-8, 13-diona - Google Patents

Un procedimiento para preparar 5,14-dihidrobenz(5,6)isoindolo(2,1-b)isoquinolein-8, 13-diona

Info

Publication number
ES8504796A1
ES8504796A1 ES526995A ES526995A ES8504796A1 ES 8504796 A1 ES8504796 A1 ES 8504796A1 ES 526995 A ES526995 A ES 526995A ES 526995 A ES526995 A ES 526995A ES 8504796 A1 ES8504796 A1 ES 8504796A1
Authority
ES
Spain
Prior art keywords
isoquinoline compound
isoquinoline
compound
isoindolo
dihydrobenz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526995A
Other languages
English (en)
Other versions
ES526995A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8504796A1 publication Critical patent/ES8504796A1/es
Publication of ES526995A0 publication Critical patent/ES526995A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR 5,14-DIHIDROBENZ5,6ISOINDOLO2,1-BISOQUINOLEIN-8,13-DIONA, DE FORMULA GENERAL (I), EN SUS DOS ALOMORFOS, DENOMINADOS FORMA A Y FORMA B.CONSISTE EN HACER REACCIONAR 2-FORMIL-3-CARBOXI-1,2,3,4-TETRAHIDROISOQUINOLEINA CON 1,4-NAFTOQUINONA, BAJO CONDICIONES DE ACTIVACION DEL CARBOXILO. EL PRODUCTO AISLADO DE FORMULA (I) SE RECRISTALIZA EN UN DISOLVENTE O SE CALIENTA EN UNA SUSPENSION DE TOLUENO, PARA OBTENER LA FORMA A; O BIEN DICHO PRODUCTO DE FORMULA (I) SE DISPERSA RAPIDAMENTE, EN SOLUCION EN UN DISOLVENTE LIQUIDO, EN UN SEGUNDO LIQUIDO QUE ES MISCIBLE EN DICHO DISOLVENTE LIQUIDO Y EN EL QUE ES INSOLUBLE EL COMPUESTO DE FORMULA (I), OBTENIENDOSE ASI LA FORMA B.DE APLICACION EN EL TRATAMIENTO DE CANCERES.
ES526995A 1982-11-04 1983-11-03 Un procedimiento para preparar 5,14-dihidrobenz(5,6)isoindolo(2,1-b)isoquinolein-8, 13-diona Granted ES526995A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8231540 1982-11-04

Publications (2)

Publication Number Publication Date
ES8504796A1 true ES8504796A1 (es) 1985-04-16
ES526995A0 ES526995A0 (es) 1985-04-16

Family

ID=10534035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526995A Granted ES526995A0 (es) 1982-11-04 1983-11-03 Un procedimiento para preparar 5,14-dihidrobenz(5,6)isoindolo(2,1-b)isoquinolein-8, 13-diona

Country Status (20)

Country Link
US (1) US4831039A (es)
EP (1) EP0108620B1 (es)
JP (1) JPS5998084A (es)
KR (1) KR900008697B1 (es)
AT (1) ATE25256T1 (es)
AU (1) AU566898B2 (es)
CA (1) CA1272198A (es)
DE (1) DE3369515D1 (es)
DK (1) DK158666C (es)
ES (1) ES526995A0 (es)
FI (1) FI74003C (es)
GB (1) GB2129799B (es)
GR (1) GR78749B (es)
IE (1) IE56206B1 (es)
IL (1) IL70124A (es)
NO (1) NO159933C (es)
NZ (1) NZ206141A (es)
PH (1) PH19013A (es)
PT (1) PT77601B (es)
ZA (1) ZA838237B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK158666C (da) * 1982-11-04 1990-11-19 Glaxo Group Ltd Analogifremgangsmaade til fremstilling af 5,14-dihydrobenz-oe5,6aa-isoindolooe2,1-baa-isoquinolin-8,13-dion
EP0161102B1 (en) * 1984-05-03 1990-02-21 Glaxo Group Limited Isoquinoline derivatives
GB8513460D0 (en) * 1985-05-29 1985-07-03 Glaxo Group Ltd Chemical compounds
NO872963L (no) * 1986-07-29 1988-02-01 Glaxo Group Ltd Isokinolinderivater.
DK616087A (da) * 1986-11-27 1988-05-28 Glaxo Group Ltd Isoquinolinderivater og farmaceutiske praeparater indeholdende dem
GB8800312D0 (en) * 1988-01-07 1988-02-10 Glaxo Group Ltd Process

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042591A (en) * 1973-05-30 1977-08-16 Sandoz Ltd. Naphthoquinone compounds
FR2387229A1 (fr) * 1977-04-13 1978-11-10 Anvar Dipyrido (4,3-b) (3,4-f) indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
FR2436786A1 (fr) * 1978-09-21 1980-04-18 Anvar Nouveaux derives des pyrido (4,3-b) carbazoles (ellipticines), substitues en position 1 par une chaine polyaminee, leur obtention et leur application a titre de medicaments
DK158666C (da) * 1982-11-04 1990-11-19 Glaxo Group Ltd Analogifremgangsmaade til fremstilling af 5,14-dihydrobenz-oe5,6aa-isoindolooe2,1-baa-isoquinolin-8,13-dion
EP0161102B1 (en) * 1984-05-03 1990-02-21 Glaxo Group Limited Isoquinoline derivatives

Also Published As

Publication number Publication date
FI74003C (fi) 1987-12-10
DK499583D0 (da) 1983-11-01
ATE25256T1 (de) 1987-02-15
AU566898B2 (en) 1987-11-05
EP0108620B1 (en) 1987-01-28
IL70124A (en) 1986-11-30
JPS5998084A (ja) 1984-06-06
DK158666C (da) 1990-11-19
GB2129799A (en) 1984-05-23
EP0108620A1 (en) 1984-05-16
NO834019L (no) 1984-05-07
CA1272198A (en) 1990-07-31
AU2096683A (en) 1984-05-10
IL70124A0 (en) 1984-02-29
PT77601A (en) 1983-12-01
KR900008697B1 (ko) 1990-11-27
US4831039A (en) 1989-05-16
FI834045A0 (fi) 1983-11-03
NO159933C (no) 1989-02-22
NO159933B (no) 1988-11-14
KR840006657A (ko) 1984-12-01
PH19013A (en) 1985-12-03
GB2129799B (en) 1986-02-26
PT77601B (en) 1986-03-18
FI74003B (fi) 1987-08-31
DE3369515D1 (de) 1987-03-05
ES526995A0 (es) 1985-04-16
IE832575L (en) 1984-05-04
GB8329342D0 (en) 1983-12-07
DK158666B (da) 1990-07-02
DK499583A (da) 1984-05-05
JPS6225668B2 (es) 1987-06-04
IE56206B1 (en) 1991-05-22
ZA838237B (en) 1984-11-28
NZ206141A (en) 1986-09-10
GR78749B (es) 1984-10-02
FI834045A (fi) 1984-05-05

Similar Documents

Publication Publication Date Title
DE3687007D1 (en) 6-thioxanthinderivate.
ES8801276A1 (es) Procedimiento para preparar nuevos derivados imidazo
ES8504796A1 (es) Un procedimiento para preparar 5,14-dihidrobenz(5,6)isoindolo(2,1-b)isoquinolein-8, 13-diona
AU587294B2 (en) Process for the preparation of vanadium- containing mixed metal soap solutions
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
GB1420739A (en) 3-alkenyl dibenzo-b,d-pyran compounds
ES8505682A1 (es) Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos
ES8701218A1 (es) Un procedimiento para la preparacion de una composicion acuosa en suspension de un combustible solido como carbon,coque de petroleo o brea.
SU1121940A1 (ru) Этиловый эфир [3-метил-5- 2′ -оксифенил)-1,2,4-триазолил-1] уксусной кислоты, обладающий психостимулирующим действием
ES8104251A1 (es) Procedimiento para preparar acetamidas
SU1167881A1 (ru) Фенилгидразид морфолинодиэтилуксусной кислоты, обладающий противотуберкулезным действием
ES8402845A1 (es) "procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas"
SU1280931A1 (ru) Катод магниевого электролизера (его варианты)
ES8304130A1 (es) "procedimiento para la preparacion de la pirido-(2,3-b)-(1,4)-benzodiacepin-6-ona".
ES8707510A1 (es) Procedimiento para preparar 6-etoxi-4-metil-benzotiazol-2(3h)-ona
SU1116706A1 (ru) Производные 2,3,4,5-тетрагидро-1н-1,5-бензодиазепинона-2, проявляющие противовоспалительную активность
JPS57189639A (en) Mannan-containing yogurt
JPS5242526A (en) Preparation of iron oxide pigment
SU1146989A1 (ru) ГИДРОХЛОРИД ОРТО-БРОМАНИЛИДА β -ДИЭТИЛАМИНОПРОПИОНОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЙ АНЕСТЕЗИРУЮЩУЮ АКТИВНОСТЬ
JPS52136155A (en) Preparation of adamantylamidines